Endocrine mechanisms of blood pressure rhythms

Annals of the New York Academy of Sciences

Volumn 783, Issue , 1996, Pages 113-131

  Portaluppi, Francesco ^a   Vergnani, Luciana ^a   Manfredini, Roberto ^a   Fersini, Carmelo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; BIOGENIC AMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; INSULIN; MELATONIN; OPIATE; OPIATE RECEPTOR; PEPTIDE; PROSTAGLANDIN E2; PROTIRELIN; SEROTONIN; STEROID; VASOACTIVE INTESTINAL POLYPEPTIDE;

AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL RHYTHM; BLOOD PRESSURE; CIRCADIAN RHYTHM; CONFERENCE PAPER; ENDOCRINE SYSTEM; HORMONE RELEASE; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROENDOCRINOLOGY; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP;

EID: 0029828623     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb26711.x     Document Type: Conference Paper

References (195)

1. MCGINTY, D. & R. SZYMUSIAK. 1994. Neurobiology of sleep. In Sleep and Breathing. N. A. Saunders & C. E. Sullivan, Eds., 71: 1-26. Marcel Dekker, Inc. New York, Basel, Hong Kong.
2. AXELROD, J. 1974. The pineal gland: A neurochemical transducer. Science 184: 1341-1348.
3. ZATZ, M. & D. A. MULLEN. 1988. Norepinephrine, acting via adenylate cyclase, inhibits melatonin output but does not phase-shift the pacemaker in cultured chick pineal cells. Brain Res. 450: 137-143.
4. STEHLE, J. H., N. S. FOULKES, C. A. MOLINA, V. SIMONNEAUX, P. PEVET & P. SASSONECORSI. 1993. Adrenergic signals direct rhythmic expression of transcriptional represser CREM in the pineal gland. Nature 365: 314-320.
5. KACHI, T., T. K. BANERJI & W. B. QUAY. 1984. Quantitative cytological analysis of functional changes in adrenomedullary chromaffin cells in normal, sham-operated, and pinealectomized rats in relation to time of day. I. Nucleolar size. J. Pineal Res. 1: 31-49.
6. YOSHIDA, T. & G. A. BRAY. 1988. Effects of food and light on norepinephrine turnover. Am. J. Physiol. 254: R821-R827.
7. CARNEIRO, R. C., J. CIPOLLA-NETO & R. P. MARKUS. 1991. Diurnal variation of the rat vas deferens contraction induced by stimulation of presynaptic nicotinic receptors and pineal function. J. Pharmacol. Exp. Ther. 259: 614-619.
8. ASCHOFF, J., S. DAAN & G. A. GROOS. 1982. Vertebrate Circadian Systems. Springer-Verlag. Berlin, Heidelberg & New York.
9. JANSSEN, B. J., C. M. TYSSEN, H. DUINDAM & W. J. RIETVELD. 1994. Suprachiasmatic lesions eliminate 24-h blood pressure variability in rats. Physiol. Behav. 55: 307-311.
10. WITTE, K., A. SCHNECKO, R. BUIJS & B. LEMMER. 1995. Circadian rhythms in blood pressure and heart rate in SCN-lesioned and unlesioned transgenic hypertensive rats (abstract). Biol. Rhythm Res. 26: 458-459.
11. 2+]-dependent ATPase in cardiac sarcolemma. J. Pineal Res. 14: 178-183.
12. COWLEY, A. W. JR., J. F. LIARD & A. C. GUYTON. 1973. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ. Res. 32: 564-576.
13. EWING, D. J., D. Q. BORSEY, P. TRAVIS, F. BELLAVERE, J. M. NEILSON & B. F. CLARKE. 1983. Abnormalities of ambulatory 24-hour heart rate in diabetes mellitus. Diabetes 32: 101-105.
14. CLEMENT, D. L., N. DE PUE, L. J. JORDAENS & L. PACKET. 1985. Adrenergic and vagal influences on blood pressure variability. Clin. Exp. Hypertens. [A] 7: 159-166.
15. LINSELL, C. R., S. L. LIGHTMAN, P. E. MULLEN, M. J. BROWN & R. C. CAUSON. 1985. Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab. 60: 1210-1215.
16. BEXTON, R. S., H. O. VALLIN & A. J. CAMM. 1986. Diurnal variation of the QT interval - influence of the autonomic nervous system. Br. Heart J. 55: 253-258.
17. MANCIA, G., G. PARATI, G. POMIDOSSI, R. CASADEI, M. DI RIENZO & A. ZANCHETTI. 1986. Arterial barorefiexes and blood pressure and heart rate variabilities in humans. Hypertension 8: 147-153.
18. KASTING, G. A., D. L. ECKBERG, J. M. FRITSCH & C. L. BIRKETT. 1987. Continuous resetting of the human carotid baroreceptor-cardiac reflex. Am. J. Physiol. 252: R732-R736.
19. PARATI, G., M. DI RIENZO, G. BERTINIERI et al. 1988. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension 12: 214-222.
20. BELL, L. B., P. K. DORWARD & C. D. RUDD. 1990. Influence of cardiac afferents on time-dependent changes in the renal sympathetic baroreflex of conscious rabbits. Clin. Exp. Pharmacol. Physiol. 17: 545-555.
21. FURLAN, R., S. GUZZETTI, W. CRIVELLARO et al. 1990. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 81: 537-547.
22. HAYANO, J., Y. SAKAKIBARA, M. YAMADA et al. 1990. Diurnal variations in vagal and sympathetic cardiac control. Am. J. Physiol. 258: H642-H646.
23. KAMATH, M. V. & E. L. FALLEN. 1991. Diurnal variations of neurocardiac rhythms in acute myocardial infarction. Am. J. Cardiol 68: 155-160.
24. MOLGAARD, H., P. D. CHRISTENSEN, K. E. SORENSEN, C. K. CHRISTENSEN & C. E. MOGENSEN. 1992. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 41: 812-817.
25. GOLDSMITH, R. L., J. T. BIGGER, R. C. STEINMAN & J. L. FLEISS. 1992. Comparison of 24-hour parasympathetic activity in endurance-trained and untrained young men. J. Am. Coll. Cardiol. 20: 552-558.
26. DETOLLENAERE, M. S., D. A. DUPREZ, M. L. DE BUYZERE, H. J. VANDEKERCKHOVE, G. G. DE BACKER & D. L. CLEMENT. 1993. 24 hour ambulatory blood pressure variability and cardiac parasympathetic function 2 and 6 weeks after acute myocardial infarction. Clin. Auton. Res. 3: 255-259.
27. HARTIKAINEN, J., I. TARKIAINEN, K. TAHVANAINEN, M. MANTYSAARI, E. LANSIMIES & K. PYORALA. 1993. Circadian variation of cardiac autonomic regulation during 24-h bed rest. Clin. Physiol. 13: 185-196.
28. SOMERS, V. K., D. PHIL, M. E. DYKEN, A. L. MARK & F. M. ABBOUD. 1993. Sympatheticnerve activity during sleep in normal subjects. N. Engl. J. Med. 328: 303-307.
29. VAN DE BORNE, P., H. NGUYEN, P. BISTON, P. LINKOWSKI & J. P. DEGAUTE. 1994. Effects of wake and sleep stages on the 24-h autonomie control of blood pressure and heart rate in recumbent men. Am. J. Physiol. 266: H548-H554.
30. TURTON, M. B. & T. DEEGAN. 1974. Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects. Clin. Chim. Acta 55: 389-397.
31. PRINZ, P. N., J. HALTER, C. BENEDETTI & M. RASKIND. 1979. Circadian variation of plasma catecholamines in young and old men: Relation to rapid eye movement and slow wave sleep. J. Clin. Endocrinol. Metab. 49: 300-304.
32. RICHARDS, A. M., M. G. NICHOLLS, E. A. ESPINER, H. IKRAM, M. CULLENS & D. HINTON. 1986. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin. Exp. Hypertens. [A] 8: 153-166.
33. KAWANO, Y., T. KAWASAKI, N. KAWAZOE et al. 1990. Circadian variations of urinary dopamine, norepinephrine, epinephrine and sodium in normotensive and hypertensive subjects. Nephron 55: 277-282.
34. KAWANO, Y., O. TOCHIKUBO, K. MINAMISAWA, E. MIYAJIMA & M. ISHII. 1994. Circadian variation of hemodynamics in patients with essential hypertension: Comparison between early morning and evening. J. Hypertens. 12: 1405-1412.
35. LAKATUA, D. J., E. HAUS, F. HALBERG et al. 1986. Circadian characteristics of urinary epinephrine and norepinephrine from healthy young women in Japan and U.S.A. Chronobiol. Int. 3: 189-195.
36. WESTERINK, B. H. & N. TEN KATE. 1986. 24 h excretion patterns of free, conjugated and methylated catecholamines in man. J. Clin. Chem. Clin. Biochem. 24: 513-519.
37. LAKATUA, D. J., G. Y. NICOLAU, C. BOGDAN et al. 1987. Chronobiology of catecholamine excretion in different age groups. Prog. Clin. Biol. Res. 227: 31-50.
38. SOWERS, J. R. & N. VLACHAKIS. 1984. Circadian variation in plasma dopamine levels in man. J. Endocrinol. Invest. 7: 341-345.
39. LEMMER, B. & T. BERGER. 1978. Diurnal rhythm in the central dopamine turnover in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 303: 257-261.
40. HUTSON, P. H., G. S. SARNA & G. CURZON. 1984. Determination of daily variations of brain 5-hydroxytryptamine and dopamine turnovers and of the clearance of their acidic metabolites in conscious rats by repeated sampling of cerebrospinal fluid. J. Neurochem. 43: 291-293.
41. SMITH, A. D., R. J. OLSON & J. B. J. JUSTICE. 1992. Quantitative microdialysis of dopamine in the striatum: Effect of arcadian variation. J. Neurosci. Methods 44: 33-41.
42. SCHWEIGER, U., M. WARNHOFF & K. M. PIRKE. 1985. Norepinephrine turnover in the hypothalamus of adult male rats: Alteration of circadian patterns by semistarvation. J. Neurochem. 45: 706-709.
43. SCHEVING, L. E., W. H. HARRISON, P. GORDON & J. E. PAULY. 1968. Daily fluctuation (circadian and ultradian) in biogenic amines of the rat brain. Am. J. Physiol. 214: 166-173.
44. KOULU, M., N. BJELOGRLIC, H. AGREN, J. M. SAAVEDRA, W. Z. POTTER & M. LINNOILA. 1989. Diurnal variation in the concentrations of catecholamines and indoleamines in the median eminence and in the intermediate and posterior lobes of the pituitary gland of the male rat. Brain Res. 503: 246-252.
45. KAFKA, M. S., M. A. BENEDITO, R. H. ROTH, L. K. STEELE, W. W. WOLFE & G. N. CATRAVAS. 1986. Circadian rhythms in catecholamine metabolites and cyclic nucleotide production. Chronobiol. Int. 3: 101-115.
46. HUIE, J. M., R. P. SHARMA & R. A. J. COULOMBE. 1989. Diurnal alterations of catecholamines, indoleamines and their metabolites in specific brain regions of the mouse. Comp. Biochem. Physiol. [C] 94: 575-579.
47. TURNER, B. B., T. E. WILENS, K. A. SCHROEDER, R. J. KATZ & B. J. CARROLL. 1981. Comparison of brainstem and adrenal circadian patterns of epinephrine synthesis. Neuroendocrinology 32: 257-261.
48. SUDO, A. 1987. Adrenaline in various organs of the rat: Its origin, location and diurnal fluctuation. Life Sci. 41: 2477-2484.
49. KUCHEL, O. & N. T. BUU. 1985. Circadian variations of free and sulfoconjugated catecholamines in normal subjects. Endocr. Res. 11: 17-25.
50. KUCHEL, O. 1994. Clinical implications of genetic and acquired defects in catecholamine synthesis and metabolism. Clin. Invest. Med. 17: 354-373.
51. SACK, D. A., S. P. JAMES, A. R. DORAN, M. A. SHERER, M. LINNOILA & T. A. WEHR. 1988. The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions. Arch. Gen. Psychiatry 45: 162-166.
52. CANDITO, M., D. PRINGUEY, Y. JACOMET et al. 1992. Circadian rhythm in plasma noradrenaline of healthy sleep-deprived subjects. Chronobiol. Int. 9: 444-447.
53. WIRZ-JUSTICE, A., I. TOBLER, M. S. KAFKA et al. 1981. Sleep deprivation: Effects on circadian rhythms of rat brain neurotransmitter receptors. Psychiatry Res. 5: 67-76.
54. KAFKA, M. S., A. WIRZ-JUSTICE & D. NABER. 1981. Circadian and seasonal rhythms in alpha- and beta-adrenergic receptors in the rat brain. Brain Res. 207: 409-419.
55. 3H-dihydroalprenolol binding and cyclic AMP content in heart ventricles of L-D synchronized rats. Pol. J. Pharmacol. Pharm. 36: 275-280.
56. MEHTA, J., M. MALLOY, D. LAWSON & L. LOPEZ. 1989. Circadian variation in platelet alpha 2-adrenoceptor affinity in normal subjects. Am. J. Cardiol. 63: 1002-1005.
57. KAFKA, M. S., A. WIRZ-JUSTICE, D. NABER, R. Y. MOORE & M. A. BENEDITO. 1983. Circadian rhythms in rat brain neurotransmitter receptors. Fed. Proc. 42: 2796-2801.
58. BRUNEL, S. & C. DE MONTIGNY. 1987. Diurnal rhythms in the responsiveness of hippocampal pyramidal neurons to serotonin, norepinephrine, gamma-aminobutyric acid and acetylcholine. Brain Res. Bull. 18: 205-212.
59. JOHANSSON, B. B. & L. MARTINSSON. 1980. The blood-brain barrier in adrenaline-induced hypertension. Circadian variations and modification by beta-adrenoreceptor antagonists. Acta Neurol. Scand. 62: 96-102.
60. MATO, M., S. OOKAWARA, K. TOOYAMA & T. ISHIZAKI. 1981. Chronobiological studies on the blood-brain barrier. Experientia 37: 1013-1015.
61. MIDDEKE, M. 1992. Synchronizität von zirkadianer Blutdruckrhythmik und sympathoadrenerger Aktivität. Z. Kardiol. 81 (Suppl. 2): 55-58.
62. GOULD, B. A. & E. B. RAFTERY. 1991. Twenty-four-hour blood pressure control: An intraarterial review. Chronobiol. Int. 8: 495-505.
63. DE LEEUW, P. W., H. E. FALKE, T. L. KHO, R. VANDONGEN, A. WESTER & W. H. BIRKENHAGER. 1977. Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. Acta Med. Scand. 202: 389-392.
64. HICKEY, M. S., D. L. COSTILL, M. D. VUKOVICH, K. KRYZMENSKI & J. J. WIDRICK. 1993. Time of day effects on sympathoadrenal and pressor reactivity to exercise in healthy men. Eur. J. Appl. Physiol. 67: 159-163.
65. SOWERS, J. R. 1981. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. J. Clin. Endocrinol. Metab. 53: 1133-1137.
66. TUCK, M. L., N. STERN & J. R. SOWERS. 1985. Enhanced 24-hour norepinephrine and renin secretion in young patients with essential hypertension: Relation with the circadian pattern of arterial blood pressure. Am. J. Cardiol. 55: 112-115.
67. THOMPSON, M. E., G. Y. NICOLAU, D. J. LAKATUA et al. 1987. Endocrine factors of blood pressure regulation in different age groups. Prog. Clin. Biol. Res. 227B: 79-95.
68. BERNARDI, M., F. TREVISANI, R. DE PALMA et al. 1987. Chronobiological evaluation of sympathoadrenergic function in cirrhosis. Relationship with arterial pressure and heart rate. Gastroenterology 93: 1178-1186.
69. BRICKMAN, A. S., N. STERN & J. R. SOWERS. 1990. Circadian variations of catecholamines and blood pressure in patients with pseudohypoparathyroidism and hypertension. Chronobiologia 17: 37-44.
70. SOWERS, J. R., M. NYBY & K. JASBERG. 1982. Dopaminergic control of prolactin and blood pressure: Altered control in essential hypertension. Hypertension 4: 431-437.
71. GEBBER, G. L. & S. M. BARMAN. 1980. Rhythmogenesis in the sympathetic nervous system. Fed. Proc. 39: 2526-2530.
72. TAPP, W. N., B. E. LEVIN & B. H. NATELSON. 1981. Ultradian rhythm of plasma norepinephrine in rats. Endocrinology 109: 1781-1783.
73. DIETL, H., H. PRAST & A. PHILIPPU. 1993. Pulsatile release of calecholamines in the hypothalamus of conscious rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 347: 28-33.
74. ROBINSON, R. L., H. DIETL, M. BALD, A. KRAUS & A. PHILIPPU. 1983. Effects of short-lasting and long-lasting blood pressure changes on the release of endogenous catecholamines in the hypothalamus of the conscious, freely moving rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 322: 203-209.
75. TAKIYYUDDIN, M. A., H. P. NEUMANN, J. H. CERVENKA et al. 1991. Ultradian variations of chromogranin A in humans. Am. J. Physiol. 261: R939-R944.
76. SIMPSON, H. W., F. C. BARTTER, F. HALBERG et al. 1990. A circaoctohoran rhythm of urine epinephrine excretion in man. Prog. Clin. Biol. Res. 341A: 157-160.
77. ROUNDS, H. D. 1984. A cholinergic receptor 12-hour interval-timer displaying "circa" periodicities. Comp. Biochem. Physiol. [C] 77: 59-63.
78. GORDON, R. D., L. K. WOLFE, D. P. ISLAND & G. W. LIDDLE. 1966. A diurnal rhythm in plasma renin activity in man. J. Clin. Invest. 45: 1587-1592.
79. KATZ, F. H., P. ROMFH & J. A. SMITH. 1972. Episodic secretion of aldosterone in supine man; relationship to cortisol. J. Clin. Endocrinol. Metab. 35: 178-181.
80. ARMBRUSTER, H., W. VETTER, R. BECKERHOFF, J. NUSSBERGER, H. VETTER & W. SIEGENTHALER. 1975. Diurnal variations of plasma aldosterone in supine man: Relationship to plasma renin activity and plasma cortisol. Acta Endocrinol. (Copenh.) 80: 95-103.
81. KATZ, F. H., P. ROMFH & J. A. SMITH. 1975. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J. Clin. Endocrinol. Metab. 40: 125-134.
82. MODLINGER, R. S., K. SHARIF-ZADEH, N. H. ERTEL & M. GUTKIN. 1976. The circadian rhythm of renin. J. Clin. Endocrinol. Metab. 43: 1276-1282.
83. LIEBAU, H. & J. MANITIUS. 1982. Diurnal and daily variations of PRA, plasma catecholamines and blood pressure in normotensive and hypertensive man. Contrib. Nephrol. 30: 57-63.
84. BEILIN, L. J., J. DEACON, C. A. MICHAEL et al. 1982. Circadian rhythms of blood pressure and pressor hormones in normal and hypertensive pregnancy. Clin. Exp. Pharmacol. Physiol. 9: 321-326.
85. FREEMAN, R. H., J. O. DAVIS, G. M. WILLIAMS & A. A. SEYMOUR. 1982. Circadian changes in plasma renin activity and plasma aldosterone concentration in one-kidney hypertensive rats. Proc. Soc. Exp. Biol. Med. 169: 86-89.
86. SHIRAKI, K., N. KONDA, S. SAGAWA, J. R. CLAYBAUGH & S. K. HONG. 1986. Cardiorenalendocrine responses to head-out immersion at night. J. Appl. Physiol. 60: 176-183.
87. KOOL, M. J., J. A. WIJNEN, F. H. DERKX, H. A. STRUIJKER BOUDIER & L. M. VAN BORTEL. 1994. Diurnal variation in prorenin in relation to other humoral factors and hemodynamics. Am. J. Hypertens. 7: 723-730.
88. MULLEN, P. E., V. H. JAMES, S. L. LIGHTMAN, C. LINSELL & W. S. PEART. 1980. A relationship between plasma renin activity and the rapid eye movement phase of sleep in man. J. Clin. Endocrinol. Metab. 50: 466-469.
89. LIGHTMAN, S. L., V. H. JAMES, C. LINSELL, P. E. MULLEN, W. S. PEART & P. S. SEVER. 1981. Studies of diurnal changes in plasma renin activity, and plasma noradrenaline, aldosterone and cortisol concentrations in man. Clin. Endocrinol. (Oxf.) 14: 213-223.
90. BRANDENBERGER, G., M. FOLLENIUS, A. MUZET, J. EHRHART & J. P. SCHIEBER. 1985. Ultradian oscillations in plasma renin activity: Their relationships to meals and sleep stages. J. Clin. Endocrinol. Metab. 61: 280-284.
91. BRANDENBERGER, G., M. FOLLENIUS, C. SIMON, J. EHRHART & J. P. LIBERT. 1988. Nocturnal oscillations in plasma renin activity and REM-NREM sleep cycles in humans: A common regulatory mechanism? Sleep 11: 242-250.
92. STUMPE, K. O., R. KOLLOCH, H. VETTER et al. 1976. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Am. J. Med. 60: 853-865.
93. NICHOLLS, M. G., E. A. ESPINER, H. IKRAM, A. H. MASLOWSKI, E. J. HAMILTON & P. J. BONES. 1984. Hormone and blood pressure relationships in primary aldosteronism. Clin. Exp. Hypertens. [A] 6: 1441-1458.
94. NAHMOD, V. E., M. S. BALDA, C. J. PIROLA, S. FINKIELMAN, P. V. GEJMAN & D. P. CARDINALI. 1982. Orcadian rhythm and neural regulation of rat pineal angiotensin converting enzyme. Brain Res. 236: 216-220.
95. VAGNUCCI, A. H., R. H. J. R. MCDONALD, A. L. DRASH & A. K. WONG. 1974. Intradiem changes of plasma aldosterone, cortisol, corticosterone and growth hormone in sodium restriction. J. Clin. Endocrinol. Metab. 38: 761-776.
96. SOWERS, J. R., N. STERN, M. D. NYBY & K. A. JASBERG. 1982. Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension. Cardiovasc. Res. 16: 317-323.
97. TAKEDA, R., I. MIYAMORI, M. IKEDA et al. 1984. Circadian rhythm of plasma aldosterone and time dependent alterations of aldosterone regulators. J. Steroid Biochem. 20: 321-323.
98. FOLLENIUS, M., M. O. KRAUTH, J. SAINI & G. BRANDENBERGER. 1992. Effect of awakening on aldosterone. J. Endocrinol. Invest. 15: 475-478.
99. CUGINI, P., R. MANCONI, R. SERDOZ, A. MANCINI, T. MEUCCI & D. SCAVO. 1980. Rhythm characteristics of plasma renin, aldosterone and cortisol in five subtypes of mesorhypertension. J. Endocrinol. Invest. 3: 143-147.
100. ATLAS, S. A., D. B. CASE, J. E. SEALEY & J. H. LARAGH. 1981. Relationship between plasma renin and cortisol in hypertensive patients. Clin. Sci. 61: S265s-S268s.
101. CAMPBELL, P. J., G. B. BOLLI, P. E. CRYER & J. E. GERICH. 1985. Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus. Metabolism 34: 1100-1104.
102. WITWORTH, J. A., D. SAINES, R. THATCHER, A. BURTKUS & B. A. SCOGGINS. 1983. Blood pressure and metabolic effects of ACTH in normotensive and hypertensive man. Clin. Exp. Hypertens. A 5: 501-522.
103. SPENCE, C. D., A. BROWN, J. P. COGHLAN, D. G. PAERKES, J. A. WITWORTH & B. A. SCOGGINS. 1989. Rapid haemodynamic response to adrenocorticotropin and the role of peripheral resistance in adrenoorticotropin-induced hypertension in conscious sheep. J. Hypertens. 7: 277-285.
104. SCOGGINS, B. A., J. P. COGHLAN, D. A. DENTON et al. 1975. The role of adrenocortical hormones in ACTH-induced hypertension. Clin. Exp. Pharmacol. Physiol. Suppl. 2: 119-122.
105. IMAI, Y., K. ABE, S. SASAKI et al. 1989. Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations. J. Hypertens. 7: 113-120.
106. IMAI, Y., K. ABE, S. SASAKI et al. 1988. Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 12: 11-19.
107. PANARELLI, M., M. TERZOLO, A. PIOVESAN et al. 1990. A 24-hour profiles of blood pressure and heart rate in Cushing's syndrome. Evidence for a differential control of cardiovascular variables by glucocorticoids. Ann. Ital. Med. Int. 5: 18-25.
108. DJAVIDANI, B., M. SANDER, R. KREUTZ et al. 1995. Chronic dexamethasone treatment suppresses hypertension development in the transgenic rat TGR(mRen2)27. J. Hypertens. 13: 637-645.
109. SCHNECKO, A., K. WITTE, A. SCHANZER & B. LEMMER. 1995. Corticosterone and aldosterone concentration in normotensive Sprague Dawley and transgenic hypertensive rats (abstract). Biol. Rhythm Res. 26: 442.
110. VAN CAUTER, E. & S. REFETEFF. 1985. Multifactorial control of the 24-hour secretory profiles of pituitary hormones. J. Endocrinol. Invest. 8: 381-391.
111. VAN DE BORNE, P., H. NGUYEN, P. LINKOWSKI & J.-P. DEGAUTE. 1993. Sleep quality and continuous, non-ivasive beat-to-beat blood pressure recording. J. Hypertens. 11: 1423-1427.
112. LEJEUNE-LENAIN, C, E. VAN CAUTER & D. DESIR. 1987. Control of circadian and episodic variations of adrenal androgen secretion in man. J. Endocrinol. Invest. 10: 267-276.
113. SOWERS, J. R. & F. W. BECK. 1983. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man. Acta Endocrinol. (Copenh.) 102: 258-264.
114. SZAFARCZYK, A., G. ALONSO, G. IXART, F. MALAVAL & I. ASSENMACHER. 1985. Diurnalstimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am. J. Physiol. 249: E219-E226.
115. JOHNSON, R. F. & W. RANDALL. 1983. Mediation of the photoperiodic effect on grooming reflexes by glucocorticoid hormones and serotonin. Behav. Neurosci. 97: 195-209.
116. KRIEGER, D. T. 1975. Effect of intraventricular neonatal 6-OH dopamine or 5,6-dihydroxytryptamine administration on the circadian periodicity of plasma corticosteroid levels in the rat. Neuroendocrinology 17: 62-74.
117. JAFFER, A., V. A. RUSSELL & J. J. TALJAARD. 1987. Noradrenergic and dopaminergic modulation of thyrotropin secretion in the rat. Brain Res. 404: 267-272.
118. BARONTINI, M., H. E. ROMEO, I. ARMANDO & D. P. CARDINALI. 1988. 24 hour changes in catecholamine content of rat thyroid and submaxillary glands. J. Neural. Transm. 71: 189-194.
119. SCANLON, M. F., A. P. WEETMAN, M. LEWIS et al. 1980. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects. J. Clin. Endocrinol. Metab. 51: 1251-1256.
120. PEREZ-LOPEZ, F. R., C. M. GONZALEZ-MORENO, M. D. ABOS, J. A. ANDONEGUI & R. H. CORVO. 1982. Pituitary response to a dopamine antagonist at different times of the day in normal women. Acta Endocrinol. (Copenh.) 100: 481-485.
121. ROSSMANITH, W. G., J. F. MORTOLA, G. A. LAUGHLIN & S. S. YEN. 1988. Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women. J. Clin. Endocrinol. Metab. 67: 560-564.
122. HURXTHAL, L. M. 1931. Blood pressure before and after operation in hyperthyroidism. Arch. Intern. Med. 47:
123. MERILLON, J. P., P. PASSA, J. CHASTRE, A. WOLF & R. GOURGON. 1981. Left ventricular function and hyperthyroidism. Br. Heart J. 46: 137-143.
124. GRAETTINGER, J. S., J. J. MUENSTER, C. S. CHECCHIA, R. L. GRISSOM & J. A. CAMPBELL. 1957. A correlation of clinical hemodynamic studies in patients with hypothyroidism. J. Clin. Invest. 1957: 502-512.
125. SAITO, I., K. ITO & T. SARUTA. 1983. Hypothyroidism as a cause of hypertension. Hypertension 5: 112-115.
126. STREETEN, D. H., G. H. ANDERSON, JR., T. HOWLAND, R. CHIANG & H. SMULYAN. 1988. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11: 78-83.
127. CARMODY, J. J. 1987. Opiate receptors: An introduction. Anaesth. Intensive Care 15: 27-37.
128. HERZ, A. 1983. Multiple opiate receptors and their functional significance. J. Neural Transm. 18(Suppl.): 227-230.
129. PASTERNACK, G. W., A. R. GINTZLER, R. A. HOUGHTON et al. 1983. Biochemical and pharmacological evidence for opioid receptor multiplicity in the central nervous system. Life Sci. 33(Suppl. 1): 167-173.
130. DUMONT, M., M. OUELLETTE, L. BRAKIER-GINGRAS & S. LEMAIRE. 1991. Circadian regulation of the biosynthesis of cardiac Met-enkephalin and precursors in normotensive and spontaneously hypertensive rats. Life Sci. 48: 1895-1902.
131. SHANKS, M. F., V. CLEMENT-JONES, C. J. LINSELL, P. E. MULLEN, L. H. REES & G. M. BESSER. 1981. A study of 24-hour profiles of plasma met-enkephalin in man. Brain Res. 212: 403-409.
132. MCINTOSH, T. K. 1987. Prolonged disruption of plasma beta-endorphin dynamics after trauma in the nonhuman primate. Endocrinology 120: 1734-1741.
133. LAUBIE, M., H. SCHMITT, M. VINCENT & G. REMOND. 1977. Central cardiovascular effects of morphinomimetic peptides in dogs. Eur. J. Pharmacol. 46: 67-71.
134. RUBIN, P., T. F. BLASCHKE & C. GUILLEMINAULT. 1981. Effect of naloxone, a specific opioid inhibitor, on blood pressure fall during sleep. Circulation 63: 117-121.
135. DOBA, N. & D. J. REIS. 1974. Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat. Circ. Res. 34: 293-301.
136. GRANDISON, L. & A. GUIDOTTI. 1977. Regulation of prolactin release by endogenous opiates. Nature 270: 357-359.
137. DUPONT, A., L. CUSAN, M. GARON, F. LABRIE & C. H. LI. 1977. Beta-endorphin: Stimulation of growth hormone release in vivo. Proc. Natl. Acad. Sci. USA 74: 358-359.
138. DEGLI UBERTI, E. C., S. SALVADORI, G. TRASFORINI et al. 1992. Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man. J. Clin. Endocrinol. Metab. 75: 370-374.
139. DEGLI UBERTI, E. C., M. R. AMBROSIO, L. VERGNANI et al. 1993. Stress-induced activation of sympathetic nervous system is attenuated by the selective ∂-opioid receptor agonist deltorphin in healthy man. J. Clin. Endocrinol. Metab. 77: 1490-1494.
140. THOREN, P., J. S. FLORAS, P. HOFFMAN & D. R. SEALS. 1990. Endorphins and exercise: Physiological mechanisms and clinical implications. Med. Sci. Sports Exerc. 22: 417-428.
141. HARA, K. & J. S. FLORAS. 1995. Influence of naloxone on muscle sympathetic nerve activity, systemic and calf haemodynamics and ambulatory blood pressure after exercise in mild essential hypertension. J. Hypertens. 13: 447-461.
142. LANG, R. E., H. K., R. DIETZ et al. 1983. Evidence for the presence of enkephalins in the heart. Life Sci. 32: 399-406.
143. VENTURA, C., L. BASTAGLI, P. BERNARDI, C. M. CALDARERA & C. GUARNIERI. 1989. Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and isoproterenolo. Biochem. Biophys. Acta 987: 69-74.
144. PORTALUPPI, F., A. PRADELLA, L. MONTANARI et al. 1990. Atrial strain is the main determinant of release of atrial natriuretic peptide. Int. J. Cardiol. 29: 297-303.
145. PORTALUPPI, F., L. VERGNANI & E. C. DEGLI UBERTI. 1993. Atrial natriuretic peptide and circadian blood pressure regulation: Clues from a chronobiological approach. Chronobiol. Int. 10: 176-189.
146. MCLAY, J. S., P. K. CHATTERJEE, A. G. JARDINE & G. M. HAWKSWORTH. 1995. Atrial natriuretic factor modulates nitric oxide production: An ANF-C receptor-mediated effect. J. Hypertens. 13: 625-630.
147. DONCKIER, J., J. V. ANDERSON, T. YEO & S. R. BLOOM. 1986. Diurnal rhythm in the plasma concentration of atrial natriuretic peptide (letter). N. Engl. J. Med. 315: 710-711.
148. WINTERS, C. J., A. L. SALLMAN & D. L. VESELY. 1988. Circadian rhythm of prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126 in man. Chronobiol. Int. 5: 403-409.
149. PORTALUPPI, F., L. MONTANARI, B. BAGNI, E. DEGLI UBERTI, G. TRASFORINI & A. MARGUTTI. 1989. Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects. Cardiology 76: 428-432.
150. MCCANCE, D. R., G. ROBERTS, B. SHERIDAN et al. 1989. Variations in the plasma concentration of atrial natriuretic factor across 24 hours. Acta Endocrinol. (Copenh.) 120: 266-270.
151. COLANTONIO, D., P. PASQUALETTI, R. CASALE & G. NATALI. 1989. Is atrial natriuretic peptide important in the circadian rhythm of arterial blood pressure? (letter). Am. J. Cardiol. 63: 1166.
152. MIYAMOTO, S., H. SHIMOKAWA, H. SUMIOKI & H. NAKANO. 1989. Physiologic role of endogenous human atrial natriuretic peptide in preeclamptic pregnancies. Am. J. Obstet. Gynecol. 160: 155-159.
153. SUMIOKI, H., H. SHIMOKAWA, S. MIYAMOTO, K. UEZONO, T. UTSUNOMIYA & H. NAKANO. 1989. Circadian variations of plasma atrial natriuretic peptide in four types of hypertensive disorder during pregnancy. Br. J. Obstet. Gynaecol. 96: 922-927.
154. PORTALUPPI, F., B. BAGNI, E. DEGLI UBERTI et al. 1990. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J. Hypertens. 8: 85-95.
155. WATANABE, M. & Y. UCHIYAMA. 1988. Twenty-four hour variations in subcellular structures of rat pancreatic islet B-, A- and D-cells, and of portal plasma glucose and insulin levels. Cell Tissue Res. 253: 337-345.
156. WEIL, J., T. M. STROM, J. M. HEIM et al. 1988. Influence of diurnal rhythm, posture and right atrial size on plasma atrial natriuretic peptide levels. Z. Kardiol. 77(Suppl. 2): 36-40.
157. PORTALUPPI, F., L. MONTANARI, L. VERGNANI et al. 1992. Loss of nocturnal increase in plasma concentration of atrial natriuretic peptide in hypertensive chronic renal failure. Cardiology 80: 312-323.
158. PORTALUPPI, F., L. MONTANARI, M. FERLINI et al. 1991. Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure. Chronobiol. Int. 8: 432-439.
159. PORTALUPPI, F., L. MONTANARI, M. FERLINI, L. VERGNANI, B. BAGNI & E. C. DEGLI UBERTI. 1992. Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide. Eur. Heart J. 13: 990-996.
160. SOTHERN, R. B., D. L. VESELY, E. L. KANABROCKI et al. 1994. Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol. Int. 12: 106-120.
161. YOSHIZAWA, T., O. SHIMMI & A. GIAID. 1990. Endothelin: A novel peptide in the posterior pituitary system. Science 247: 462-464.
162. BOULANGER, C. & T. F. LUSCHER. 1990. Release of endothelin from porcine aorta: Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587-590.
163. SAITO, Y., K. NAKAO, M. MUKOYAMA & H. IMURA. 1990. Increased plasma endothelin level in patients with essential hypertension (letter). N. Engl. J. Med. 322: 205.
164. FUKUDA, Y., Y. HIRATA, S. TAKETANI et al. 1989. Endothelin stimulates accumulations of cellular atrial natriuretic peptide and its messenger RNA in rat cardiocytes. Biochem. Biophys. Res. Commun. 164: 1431-1436.
165. PERFETTO, F., R. TAROUINI, A. PILUSO et al. 1995. Sex difference, age and circadian rhythmometry of circulating endothelin-1 (abstract). Biol. Rhythm Res. 26: 432.
166. AMARA, S. G., V. JONAS, M. G. ROSENFELD, E. S. ONG & R. M. EVANS. 1982. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240-244.
167. KAWAI, Y., K. TAKAMI, S. SHIOSAKA et al. 1985. Topographic localization of calcitonin gene-related peptide in the rat brain: An immunohistochemical analysis. Neuroscience 15: 747-763.
168. ROSENFELD, M. G., S. G. AMARA & R. M. EVANS. 1984. Alternative RNA processing: Determining neuronal phenotype. Science 225: 1315-1320.
169. TSCHOPP, F. A., P. H. TOBLER & J. A. FISCHER. 1984. Calcitonin gene-related peptide in the human thyroid, pituitary and brain. Mol. Cell Endocrinol. 36: 53-57.
170. TSCHOPP, F. A., H. HENKE, J. B. PETERMANN et al. 1985. Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc. Natl. Acad. Sci. USA 82: 248-252.
171. SKOFITSCH, G. & D. M. JACOBOWITZ. 1985. Autoradiographic distribution of 1251 calcitonin gene-related peptide binding sites in the rat central nervous system. Peptides 6: 975-986.
172. SKOFITSCH, G. & D. M. JACOBOWITZ. 1985. Calcitonin gene-related peptide: Detailed immunohistochemical distribution in the central nervous system. Peptides 6: 721-745.
173. SKOFITSCH, G. & D. M. JACOBOWITZ. 1985. Quantitative distribution of calcitonin gene-related peptide in the rat central nervous system. Peptides 6: 1069-1073.
174. MULDERRY, P. K., M. A. GHATEI, J. RODRIGO et al. 1985. Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience 14: 947-954.
175. WIMALAWANSA, S. J. & I. MACINTYRE. 1988. Calcitonin gene-related peptide and its specific binding sites in the cardiovascular system of rat. Int. J. Cardiol. 20: 29-37.
176. UDDMAN, R., L. EDVINSSON, E. EKBLAD, R. HAKANSON & F. SUNDLER. 1986. Calcitonin gene-related peptide (CGRP): Perivascular distribution and vasodilatory effects. Regul. Pept. 15: 1-23.
177. BENDTSEN, F., S. SCHIFTER & J. H. HENRIKSEN. 1991. Increased circulating Calcitonin gene-related peptide (CGRP) in cirrhosis. J. Hepatol. 12: 118-123.
178. GIRGIS, S. I., D. W. MACDONALD, J. C. STEVENSON et al. 1985. Calcitonin gene-related peptide: Potent vasodilator and major product of Calcitonin gene. Lancet 2: 14-16.
179. BRAIN, S. D., T. J. WILLIAMS, J. R. TIPPINS, H. R. MORRIS & I. MACINTYRE. 1985. Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54-56.
180. GOODMAN, E. C. & L. L. IVERSEN. 1986. Calcitonin gene-related peptide: Novel neuropeptide. Life Sci. 38: 2169-2178.
181. TIFFINS, J. R. 1986. CGRP: a novel neuropeptide from the Calcitonin gene is the most potent vasodilator known. J. Hypertens. 4: S102-S105.
182. STRUTHERS, A. D., M. J. BROWN, D. W. MACDONALD et al. 1986. Human Calcitonin gene related peptide: A potent endogenous vasodilator in man. Clin. Sci. 70: 389-393.
183. MCEWAN, J., S. LARKIN, G. DAVIES et al. 1986. Calcitonin gene-related peptide: A potent dilator of human epicardial coronary arteries. Circulation 74: 1243-1247.
184. EZRA, D., F. R. LAURINDO, D. S. GOLDSTEIN, R. E. GOLDSTEIN & G. FEUERSTEIN. 1987. Calcitonin gene-related peptide: A potent modulator of coronary flow. Eur. J. Pharmacol. 137: 101-105.
185. DIPETTE, D. J., K. SCHWARZENBERGER, N. KERR & O. B. HOLLAND. 1987. Systemic and regional hemodynamic effects of calcitonin gene-related peptide. Hypertension. 9: III142-III146.
186. LAPPE, R. W., M. J. SLIVJAK, J. A. TODT & R. L. WENDT. 1987. Hemodynamic effects of calcitonin gene-related peptide in conscious rats. Regul. Pept. 19: 307-312.
187. WANG, B. C., P. BIE, R. J. J. LEADLEY & K. L. GOETZ. 1989. Cardiovascular effects of calcitonin gene-related peptide in conscious dogs. Am. J. Physiol. 257: R726-R731.
188. KURTZ, A., R. MUFF & J. A. FISCHER. 1989. Calcitonin gene products and the kidney. Klin. Wochenschr. 67: 870-875.
189. GENNARI, C. & J. A. FISCHER. 1985. Cardiovascular action of calcitonin gene-related peptide in humans. Calcif. Tissue Int. 37: 581-584.
190. PORTALUPPI, F., L. VERGNANI, A. MARGUTTI et al. 1993. Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man. J. Clin. Endocrinol. Metab. 77: 816-820.
191. TRASFORINI, G., A. MARGUTTI, L. VERGNANI et al. 1994. Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man. J. Clin. Endocrinol. Metab. 78: 763-766.
192. TRASFORINI, G., A. MARGUTTI, F. PORTALUPPI et al. 1991. Orcadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73: 945-951.
193. DE LOS SANTOS, E. T. & E. L. MAZZAFERRI. 1991. Calcitonin gene-related peptide: 24-hour profile and responses to volume contraction and expansion in normal men. J. Clin. Endocrinol. Metab. 72: 1031-1035.
194. PORTALUPPI, F., G. TRASFORINI, A. MARGUTTI et al. 1992. Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10: 1227-1234.
195. KATZ, F. H., J. A. SMITH, J. P. LOCK & D. E. LOEFFEL. 1979. Plasma vasopressin variation and renin activity in normal active humans. Horm. Res. 10: 289-302.